X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs UNICHEM LAB - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA UNICHEM LAB ALEMBIC PHARMA/
UNICHEM LAB
 
P/E (TTM) x 24.4 -66.6 - View Chart
P/BV x 6.8 0.7 916.6% View Chart
Dividend Yield % 0.7 2.3 30.4%  

Financials

 ALEMBIC PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
UNICHEM LAB
Mar-18
ALEMBIC PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs792382 207.3%   
Low Rs443234 189.2%   
Sales per share (Unadj.) Rs167.0116.3 143.6%  
Earnings per share (Unadj.) Rs38.2-18.9 -201.7%  
Cash flow per share (Unadj.) Rs42.0-11.7 -357.7%  
Dividends per share (Unadj.) Rs4.005.00 80.0%  
Dividend yield (eoy) %0.61.6 39.9%  
Book value per share (Unadj.) Rs84.9381.0 22.3%  
Shares outstanding (eoy) m188.5270.34 268.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x3.72.6 139.5%   
Avg P/E ratio x16.2-16.3 -99.4%  
P/CF ratio (eoy) x14.7-26.2 -56.0%  
Price / Book Value ratio x7.30.8 899.4%  
Dividend payout %10.5-26.4 -39.7%   
Avg Mkt Cap Rs m116,38321,668 537.1%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m4,2142,006 210.0%   
Avg. sales/employee Rs ThNM3,587.8-  
Avg. wages/employee Rs ThNM880.0-  
Avg. net profit/employee Rs ThNM-583.7-  
INCOME DATA
Net Sales Rs m31,4878,180 384.9%  
Other income Rs m55610 9.0%   
Total revenues Rs m31,5428,790 358.8%   
Gross profit Rs m10,060-1,320 -762.0%  
Depreciation Rs m722505 143.0%   
Interest Rs m3780 45.9%   
Profit before tax Rs m9,356-1,295 -722.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2-2 68.2%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,16033 6,463.8%   
Profit after tax Rs m7,194-1,331 -540.6%  
Gross profit margin %31.9-16.1 -198.0%  
Effective tax rate %23.1-2.6 -894.9%   
Net profit margin %22.8-16.3 -140.4%  
BALANCE SHEET DATA
Current assets Rs m15,06623,318 64.6%   
Current liabilities Rs m7,6744,635 165.6%   
Net working cap to sales %23.5228.4 10.3%  
Current ratio x2.05.0 39.0%  
Inventory Days Days67122 55.0%  
Debtors Days Days41121 33.4%  
Net fixed assets Rs m8,2378,163 100.9%   
Share capital Rs m377141 267.9%   
"Free" reserves Rs m15,41626,660 57.8%   
Net worth Rs m16,00526,801 59.7%   
Long term debt Rs m03 0.0%   
Total assets Rs m24,59431,890 77.1%  
Interest coverage x255.2-15.2 -1,682.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.3 499.1%   
Return on assets %29.4-3.9 -749.6%  
Return on equity %44.9-5.0 -905.1%  
Return on capital %58.7-4.5 -1,291.9%  
Exports to sales %55.70-   
Imports to sales %10.40-   
Exports (fob) Rs m17,551NA-   
Imports (cif) Rs m3,283NA-   
Fx inflow Rs m17,8114,356 408.8%   
Fx outflow Rs m5,3180-   
Net fx Rs m12,4934,356 286.8%   
CASH FLOW
From Operations Rs m9,304-1,123 -828.2%  
From Investments Rs m-3,10516,487 -18.8%  
From Financial Activity Rs m-1,959-8,811 22.2%  
Net Cashflow Rs m4,2406,552 64.7%  

Share Holding

Indian Promoters % 74.1 50.1 147.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 15.1 19.2%  
FIIs % 9.1 3.0 303.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 31.7 43.8%  
Shareholders   49,328 20,176 244.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  CADILA HEALTHCARE  NOVARTIS  PANACEA BIOTECH  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 207 Points Higher; Healthcare Stocks Witness Buying(Closing)

Indian share markets continued to trade in the green during the closing hours of the trading session and ended the day on a positive note.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 42.6% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, ALEMBIC PHARMA has posted a net profit of Rs 904 m (up 42.6% YoY). Sales on the other hand came in at Rs 9 bn (up 33.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

How to Make Big Profits by Following India's Best Investors(The 5 Minute Wrapup)

Aug 3, 2018

In a time when stocks recommended by so-called 'gurus of the market' are crashing, let Kunal Thanvi guide you to the best gurus...and their best stocks.

The Biggest Mistake You Can Make in this Market (and 3 Stocks to Buy Now!)(Profit Hunter)

Aug 3, 2018

This price pattern can help you identify stocks on the verge of a turnaround.

Does This Indicator Tell Us the Sensex is Headed for a Correction?(Vivek Kaul's Diary)

Aug 3, 2018

To what extent have foreign flows influenced Indian stock markets? How do we see it panning out now?

Is Franklin India Smaller Companies Fund Worth Your Money(Outside View)

Aug 2, 2018

Although positioned as a small cap fund, Franklin India Smaller Companies Fund has been investing a significant portion of its assets in mid-caps along with a nominal exposure to large caps.

Why HDFC Equity Fund Disappointed Its Investors(Outside View)

Aug 9, 2018

Though popular, HDFC Equity Fund is not among the best performers anymore. Here is the reason behind its underperformance that has left investors disappointed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Aug 14, 2018 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 5-YR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS